Role of Aragwadha Patra in the treatment of Dadru Kushtha

Pharmacotherapeutic Study of Aragwadha Patra (Cassia Fistula Linn.) in the Management of Dadru Kushtha W.S.R. To Tinea Infection - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069369

Enrollment

Registered

2024-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with clinical sign and symptoms of Dadru kushtha. 2.Patients of either sex from age 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1.The patients suffering from severe systemic disorders. 2.The pregnant women and lactating mother will be excluded. 3.Known case of skin malignancy.

Design outcomes

Secondary

Measure	Time frame
Changes in the Ayurvedic classical signs and symptoms of Dadru LesionsTimepoint: 30 Days	—

Primary

Measure	Time frame
Changes in number and size of DadruTimepoint: 4 week	—

Countries

India

Contacts

Public ContactDr Ganpat Lal Kumawat

National Institute of Ayurveda deemed to be university Jaipur

armurthy_2005@yahoo.com9314513659

Outcome results